Related Experiment Video
Updated: Aug 18, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
[Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol]
Marcelo del Castillo1, Nestor Wainsztein, Francisco Klein
1FLENI (Instituto de Investigaciones Neurológicas Raúl Carrea), Buenos Aires, Argentina. mdelcastillo@fleni.org.ar
Abstract:
Fungal endocarditis, in particular due to Candida species, requires medical and surgical treatment and amphotericin B is the drug of choice. Caspofungin is an echinocandin very effective against Candida and Aspergillus. We present a patient with Candida tropicalis endocarditis, fluconazol resistant, treated with caspofungin, on a compassional basis as a result of adverse effects with amphotericin B. The patient had a microbiological response.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Cryptococcal Meningitis
Candidiasis
Antifungal Agents

